These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9517520)

  • 1. Effect of mental stress and cisapride on autonomic nerve functions in functional dyspepsia.
    Hveem K; Svebak S; Hausken T; Berstad A
    Scand J Gastroenterol; 1998 Feb; 33(2):123-7. PubMed ID: 9517520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.
    Hveem K; Hausken T; Svebak S; Berstad A
    Scand J Gastroenterol; 1996 May; 31(5):452-7. PubMed ID: 8734341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
    al-Quorain A; Larbi EB; al-Shedoki F
    Scand J Gastroenterol; 1995 Jun; 30(6):531-4. PubMed ID: 7569759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low vagal tone and antral dysmotility in patients with functional dyspepsia.
    Hausken T; Svebak S; Wilhelmsen I; Haug TT; Olafsen K; Pettersson E; Hveem K; Berstad A
    Psychosom Med; 1993; 55(1):12-22. PubMed ID: 8446737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
    Deruyttere M; Lepoutre L; Heylen H; Samain H; Pennoit H
    Clin Ther; 1987; 10(1):44-51. PubMed ID: 3329964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial.
    Yeoh KG; Kang JY; Tay HH; Gwee KA; Tan CC; Wee A; Teh M; Choo HF; Chintana-Wilde W
    J Gastroenterol Hepatol; 1997 Jan; 12(1):13-8. PubMed ID: 9076616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial.
    Fumagalli I; Hammer B
    Scand J Gastroenterol; 1994 Jan; 29(1):33-7. PubMed ID: 8128175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
    Chung JM
    Scand J Gastroenterol Suppl; 1993; 195():11-4. PubMed ID: 8516653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia].
    Wang B; Liang X; Jia B
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):180-4. PubMed ID: 7648940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease.
    Jost WH; Schimrigk K
    Wien Klin Wochenschr; 1994; 106(21):673-6. PubMed ID: 7810153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA; Jessen LM; Colaizzi JL; Bierman RH
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
    Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
    Camilleri M; Balm RK; Zinsmeister AR
    Gastroenterology; 1994 Apr; 106(4):916-23. PubMed ID: 8143996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
    Halter F; Miazza B; Brignoli R
    Scand J Gastroenterol; 1994 Jul; 29(7):618-23. PubMed ID: 7939398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
    Wood SF; Penney SC; Cochran KM
    Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.